Literature DB >> 29097412

Brain Structural Changes following HIV Infection: Meta-Analysis.

E E O'Connor1, Timothy A Zeffiro2, Thomas A Zeffiro2.   

Abstract

BACKGROUND: Numerous studies have used structural neuroimaging to measure HIV effects on brain macroarchitecture. While many have reported changes in total brain volume, gray matter volume, white matter volume, CSF volume, and basal ganglia volume following HIV infection, quantitative inconsistencies observed across studies are large.
PURPOSE: Our aim was to evaluate the consistency and temporal stability of serostatus effects on a range of structural neuroimaging measures. DATA SOURCES: PubMed, reference lists, and corresponding authors. STUDY SELECTION: The meta-analysis included 19 cross-sectional studies reporting HIV effects on cortical and subcortical volume from 1993 to 2016. DATA ANALYSIS: Random-effects meta-analysis was used to estimate individual study standardized mean differences and study heterogeneity. Meta-regression was used to examine the effects of the study publication year. DATA SYNTHESIS: Meta-analysis revealed standardized mean differences related to the serostatus of -0.65 (P = .002) for total brain volume, -0.28 for gray matter volume (P = .008), -0.24 (P = .076) for white matter volume, and 0.56 (P = .001) for CSF volume. Basal ganglia volume differences related to serostatus were not significant. Nevertheless, estimates of between-study heterogeneity suggested that much of the observed variance was between studies. Publication year was associated with recent reductions in many neurostructural effects. LIMITATIONS: Many studies pooled participants with varying durations of treatment, disease, and comorbidities. Image-acquisition methods changed with time.
CONCLUSIONS: While published studies of HIV effects on brain structure had substantial variations that are likely to result from changes in HIV treatment practice during the study period, quantitative neurostructural measures can reliably detect the effects of HIV infection during treatment, serving as reliable biomarkers.
© 2018 by American Journal of Neuroradiology.

Entities:  

Mesh:

Year:  2017        PMID: 29097412     DOI: 10.3174/ajnr.A5432

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  20 in total

1.  Childhood trauma interacts with ApoE to influence neurocognitive function in women living with HIV.

Authors:  Jacqueline S Womersley; Georgina Spies; Soraya Seedat; Sian M J Hemmings
Journal:  J Neurovirol       Date:  2018-11-26       Impact factor: 2.643

2.  Use of Neuroimaging to Inform Optimal Neurocognitive Criteria for Detecting HIV-Associated Brain Abnormalities.

Authors:  Laura M Campbell; Christine Fennema-Notestine; Rowan Saloner; Mariam Hussain; Anna Chen; Donald Franklin; Anya Umlauf; Ronald J Ellis; Ann C Collier; Christina M Marra; David B Clifford; Benjamin B Gelman; Ned Sacktor; Susan Morgello; J Allen McCutchan; Scott Letendre; Igor Grant; Robert K Heaton
Journal:  J Int Neuropsychol Soc       Date:  2019-10-02       Impact factor: 2.892

3.  Effects of comorbidity burden and age on brain integrity in HIV.

Authors:  Rowan Saloner; Robert K Heaton; Laura M Campbell; Anna Chen; Donald Franklin; Ronald J Ellis; Ann C Collier; Christina Marra; David B Clifford; Benjamin Gelman; Ned Sacktor; Susan Morgello; J Allen McCutchan; Scott Letendre; Igor Grant; Christine Fennema-Notestine
Journal:  AIDS       Date:  2019-06-01       Impact factor: 4.177

4.  Global and regional brain hypometabolism on FDG-PET in treated HIV-infected individuals.

Authors:  Dima A Hammoud; Sanhita Sinharay; Sally Steinbach; Paul G Wakim; Katrina Geannopoulos; Katherine Traino; Amit K Dey; Edmund Tramont; Stanley I Rapoport; Joseph Snow; Nehal N Mehta; Bryan R Smith; Avindra Nath
Journal:  Neurology       Date:  2018-09-26       Impact factor: 9.910

5.  HIV infection and age effects on striatal structure are additive.

Authors:  Erin E O'Connor; Timothy Zeffiro; Oscar L Lopez; James T Becker; Thomas Zeffiro
Journal:  J Neurovirol       Date:  2019-04-26       Impact factor: 2.643

6.  Brain structural correlates of trajectories to cognitive impairment in men with and without HIV disease.

Authors:  Mikhail Popov; Samantha A Molsberry; Fabrizio Lecci; Brian Junker; Lawrence A Kingsley; Andrew Levine; Eileen Martin; Eric Miller; Cynthia A Munro; Ann Ragin; Eric Seaberg; Ned Sacktor; James T Becker
Journal:  Brain Imaging Behav       Date:  2020-06       Impact factor: 3.978

7.  Reductions in Gray Matter Linked to Epigenetic HIV-Associated Accelerated Aging.

Authors:  Brandon J Lew; Mikki D Schantell; Jennifer O'Neill; Brenda Morsey; Tina Wang; Trey Ideker; Susan Swindells; Howard S Fox; Tony W Wilson
Journal:  Cereb Cortex       Date:  2021-07-05       Impact factor: 5.357

8.  Association of White Matter Hyperintensities With HIV Status and Vascular Risk Factors.

Authors:  Yair Mina; Tianxia Wu; Hsing-Chuan Hsieh; Dima A Hammoud; Swati Shah; Chuen-Yen Lau; Lillian Ham; Joseph Snow; Elizabeth Horne; Anuradha Ganesan; Stanley I Rapoport; Edmund C Tramont; Daniel S Reich; Brian K Agan; Avindra Nath; Bryan R Smith
Journal:  Neurology       Date:  2021-02-26       Impact factor: 9.910

9.  Accelerated Brain Aging and Cerebral Blood Flow Reduction in Persons With Human Immunodeficiency Virus.

Authors:  Kalen J Petersen; Nicholas Metcalf; Sarah Cooley; Dimitre Tomov; Florin Vaida; Robert Paul; Beau M Ances
Journal:  Clin Infect Dis       Date:  2021-11-16       Impact factor: 9.079

10.  Effects of integrase inhibitor-based antiretroviral therapy on brain outcomes according to time since acquisition of HIV-1 infection.

Authors:  Anna Prats; Ignacio Martínez-Zalacaín; Beatriz Mothe; Eugènia Negredo; Núria Pérez-Álvarez; Maite Garolera; Sira Domènech-Puigcerver; Pep Coll; Michael Meulbroek; Anna Chamorro; Carmina R Fumaz; Maria J Ferrer; Bonaventura Clotet; Carles Soriano-Mas; Jose A Muñoz-Moreno
Journal:  Sci Rep       Date:  2021-05-28       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.